Sign in

MSF Access

@msfaccess.org
309 followers 289 following 179 posts
PostsRepliesMedia
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 23/09/2026
Our programmes in Malawi and Mali contribute to showing that it is possible to diagnose, prevent, and treat cancer in fragile and humanitarian settings. We’re speaking at the World Cancer Conference this week to share our experience:
msf.me
Delivering cancer care to women in humanitarian crises is possible | MSF
MSF will speak at the World Cancer Congress this week, sharing experiences from treating women with cancer in Mali and Malawi.
053
MSF Access @msfaccess.org · 24/09/2026
“Funders, researchers and policymakers engaged in therapeutics' clinical trials must act now to include the right access conditions in a transparent way,” said Dr Monica Rull, MSF Access
001
MSF Access @msfaccess.org · 24/09/2026
Publicly available information on pricing, licensing, supply, and post-trial access remains very limited despite repeated calls for transparency.
Analysis of 3 Ebola therapeutics candidates being used in clinical trials in DRC presentlyAnalysis of 3 Ebola therapeutics candidates being used in clinical trials in DRC presently
111
MSF Access @msfaccess.org · 24/09/2026
MSF published a technical brief analysing access challenges concerning three Bundibugyo Ebola Virus therapeutic candidates - MBP134, remdesivir, and obeldesivir. msfaccess.org/therapeutics...
msfaccess.org
Therapeutics for the 2026 Bundibugyo Ebola disease outbreak: Access gaps and recommendations
Technical brief on Ebola therapeutics and key factors affecting access
121
MSF Access @msfaccess.org · 22/09/2026
Médecins Sans Frontières (MSF)/Doctors Without Borders is pleased to announce @kristorgeson.bsky.social as the new Executive Director of MSF Access. msfaccess.org/kris-torgeso...
msfaccess.org
Kris Torgeson starts as new Executive Director for MSF Access
Médecins Sans Frontières (MSF)/Doctors Without Borders is pleased to announce Kris Torgeson as the new Executive Director of MSF Access, bringing more than two decades of experience in global health a...
031
MSF Access @msfaccess.org · 01/09/2026
In a commentary published in The Lancet today, MSF calls for urgent action to ensure children are included in Bundibugyo research on treatment and prevention and have timely access to paediatric formulations for oral post-exposure prophylaxis trials. www.thelancet.com/journals/lan...
thelancet.com
An urgent opportunity to ensure children's access to oral post-exposure prophylaxis trials for Bundibugyo virus disease
Children and pregnant women are known to be at high risk of death from Ebola virus disease.1,2 In the current outbreak of Bundibugyo virus in the Democratic Republic of the Congo, the inequality in ou...
021
Reposted by MSF Access
James Elliott @jandelliott.bsky.social · 18/08/2026
End the global standards in #diabetes care - happy to co-author this piece in @genevahealthfiles.bsky.social newsletter.genevahealthfiles.com/end-the-glob... #globalhealth
newsletter.genevahealthfiles.com
End The Global Double Standards in Diabetes Care [Guest Essay]
If You Work in Global Health, You Cannot Do Without Reading Us
011
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 23/07/2026
💢 Antimicrobial resistance brings added dangers to communities during conflict. Read on to learn more 👇
msf.org
Saving lives and limbs in conflict | MSF
Alongside addressing the physical and psychological wounds resulting from conflict, MSF faces another more insidious threat to health following trauma injuries: antimicrobial-resistant infections.
053
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 05/08/2026
📊 Now that our tuberculosis project has concluded in Manila, Philippines, we’re reflecting on five years of work, during which we screened 51,000+ people for the disease. 
msf.org
Legacy of community led tuberculosis response in Manila | MSF
MSF's project in Manila, Philippines, has been handed over to local partners, leaving a legacy of community-led tuberculosis response.
061
MSF Access @msfaccess.org · 05/08/2026
🤔 Testing, testing: what do you know about Ebola tests? 📩 ...and, take the opportunity to subscribe to our newsletter right before the August issue! msfaccess.org/newsletter/h...
msfaccess.org
Test: have you heard about tests?
Ensuring sustainable, adapted, ready and available diagnostic capacity is critical for a quick response to disease outbreak, and in the current Ebola outbreak, this must be a priority.
020
MSF Access @msfaccess.org · 31/07/2026
#AIDS2026
000
MSF Access @msfaccess.org · 30/07/2026
Together, these studies strengthen the evidence base on the benefits of analogue insulin, especially for people living with diabetes in low-resource and humanitarian settings. To improve diabetes care globally, analogue insulins must be accessible and affordable for all.
100
MSF Access @msfaccess.org · 30/07/2026
Luo et al (2026), in the HumAn-1 trial, conducted in Bangladesh and Tanzania, found “participants in the [insulin analogue] group spent less time in the very low range [hypoglycaemia] and had a reduced number of nocturnal hypoglycaemic events.” www.thelancet.com/journals/lan...
thelancet.com
Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial
At 6 months, children and young people with type 1 diabetes living in low-resource settings randomly assigned to glargine had no evidence of effects on time in very low range and time in target range ...
100
MSF Access @msfaccess.org · 30/07/2026
Masri et al (2026), an MSF study among children with Type 1 diabetes in Lebanon, a country affected by protracted humanitarian crises, showed that, “the use of analogue insulins was associated with improved glycemic control." becarispublishing.com/doi/10.57264...
becarispublishing.com
Becaris Publishing
200
MSF Access @msfaccess.org · 30/07/2026
NEW EVIDENCE: Analogue #insulin is associated with improved management & regulation of blood sugar levels for people with #diabetes. Data from two new studies in low- and middle-income countries, including those affected by humanitarian crises, below. 👇
220
MSF Access @msfaccess.org · 29/07/2026
We are taking our demand directly to Gilead at the #AIDS2026 conference in Rio de Janeiro, Brazil - a country where people still can't access lenacapavir, even when they contributed to the clinical trials for this breakthrough HIV drug. Read more: www.instagram.com/p/DbThjxUH4gy/
164
MSF Access @msfaccess.org · 28/07/2026
It's #WorldHepatitisDay and over a quarter of a million children are still acquiring chronic hepatitis B at birth each year, resulting in many premature deaths. But this can be prevented👇
012
MSF Access @msfaccess.org · 07/07/2026
By introducing analogue insulin pens to its SHA benefits package, Kenya would be leading the charge towards upending the global double standard in diabetes care and ensuring that people have more equitable access to care.” -- Dr Elizabeth Jarman, MSF msfaccess.org/msf-proposal...
msfaccess.org
MSF proposal for Kenya’s Social Health Authority (SHA) benefits package to include analogue insulin pens to improve care for people living with diabetes
MSF proposal for inclusion of insulin analogue pens and pen needles into Kenyan Social Health Authority benefits package
021
MSF Access @msfaccess.org · 07/07/2026
Today, MSF called for the inclusion of analogue insulin pens to Kenya’s Social Health Authority (SHA) benefits package. Doing so would align with Kenyan and WHO guidelines, and ensure that more people have access to more efficacious and person-preferred treatments.
111
MSF Access @msfaccess.org · 25/06/2026
This technical briefer highlights these persistent gaps and calls on all stakeholders involved in this response to ensure access not only to the diagnostic tools, but also to the systems required to use them effectively.
msfaccess.org
The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
A technical briefer sharing gaps and access priorities to ensure access to right diagnostics for Bundibugyo Ebola virus outbreak in DRC and Uganda.
010
MSF Access @msfaccess.org · 25/06/2026
The Ebola disease outbreak in eastern Democratic Republic of the Congo (DRC) and Uganda revealed a critical diagnostic blind spot in existing Ebola surveillance and testing systems. DRC authorities have expanded laboratory testing capacity, but timely access remains a challenge.
120
MSF Access @msfaccess.org · 24/06/2026
It's time to translate lessons learned from past Ebola outbreaks into timely access to medical tools for affected communities and countries. @doctorswithoutborders.org urged countries to act now: www.doctorswithoutborders.org/latest/msf-u...
doctorswithoutborders.org
MSF statement at the UN multi-stakeholder hearing on pandemic prevention, preparedness, and response (PPPR)
Response to Ebola disease outbreak highlights urgent need to center affected communities in global health decision-making
024
Reposted by MSF Access
Doctors Without Borders @doctorswithoutborders.org · 17/06/2026
A drug exists that is nearly 100% effective at preventing HIV and only needs to be taken twice a year. It's called lenacapavir. But Gilead, the company that controls it, isn't making enough available for the world. We know Gilead can make lenacapavir more accessible.
24840
MSF Access @msfaccess.org · 19/06/2026
This Ebola disease outbreak once again exposes persistent failures to ensure that accessible medical tools for diseases disproportionately affecting low- and middle-income countries are prioritised, funded, and produced as part of R&D. It has to change now. msfaccess.org/principles-e...
021
MSF Access @msfaccess.org · 18/06/2026
❓ What’s an access ____________ gap? 👉 Bridging these gaps and protecting people’s basic right to access healthcare is not easy, but it is possible, and we’re working on it. 👇 Read our latest newsletter to find out more! msfaccess.org/newsletter/w...
msfaccess.org
What’s an access ____ gap?
These gaps manifest themselves in many ways, from conflicts that delay lifesaving vaccines from being delivered to people, fuelling deadly, vaccine-preventable disease outbreaks, to failures to attach...
043
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 16/06/2026
⏰ “This outbreak can still be brought under control, but the window for action is narrowing.” One month after the Ebola disease outbreak was declared in DRC, major gaps in surveillance, diagnosis, contact tracing and community engagement persist.
msf.me
DRC: MSF warns dangerous gaps persist in Ebola disease response | MSF
Despite the recent scale-up in the Ebola disease response in Democratic Republic of Congo (DRC), major gaps in surveillance, diagnosis, contact tracing and community engagement persist.
053
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 10/05/2026
In San Pedro Sula, Honduras, we're improving access to sexual and reproductive health services for adolescents.  🎥 Diana Dáila, our medical activity manager in Honduras, tells us how her team provides this care.
031
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 27/05/2026
Cancer is becoming one of the most serious health challenges in Papua New Guinea. Patients often come in late for care, and there is limited capacity for diagnosis and treatment. Our new cancer initiative in Morobe province is addressing gaps in care:
msf.me
Papua New Guinea: Strengthening cancer care in Morobe | MSF
A new MSF project in Papua New Guinea is strengthening cancer care, including palliative care, at ANGAU Memorial Provincial hospital, in collaboration with local authorities.
011
MSF Access @msfaccess.org · 08/06/2026
Read our statement sharing principles to follow for equitable access to medical tools for Ebola disease caused by Bundibugyo virus: msfaccess.org/principles-e...
msfaccess.org
Principles for equitable access to medical tools for Ebola disease caused by Bundibugyo virus
MSF calls for following R&D Principles for equitable access to medical tools for Bundibugyo virus
012
MSF Access @msfaccess.org · 08/06/2026
With no validated treatments or vaccines yet, and limited diagnostics for Bundibugyo virus disease, R&D and funding must embed transparent and enforceable conditions from the outset to guarantee timely, sustainable access to affordable medical tools for the most affected communities.
Ebola disease caused by the Bundibugyo virus.
What is different this time?
- No validated therapeutics or vaccines
- Limited diagnostic tools
Bundibugyo virus is different than other virus causing Ebola disease.Rapid initiatives, resources and actions are being mobilised at national, regional and international levels.

Now is the time to ensure that conditions that guarantee access are embedded in R&D and funding initiatives.Principles to ensure access for the most affected people and countries:
- Affected people, communities and countries must be at the front and centre of R&D and access decisions. 
- Ensure enforceable access conditions across R&D funding governance
- Transparency and accountability should guide publicly funded response and coordination
110
Reposted by MSF Access
Doctors Without Borders / Médecins Sans Frontières (MSF) @msf.ca · 01/06/2026
#Ebola outbreaks: There are currently no approved vaccines or treatments available for the #Bundibugyo virus. Our teams, along the Democratic Republic of Congo’s MOH are working to contain the spread of the disease and strengthen patient care: www.doctorswithoutborders.ca/democratic-r...
19142
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 29/05/2026
In eastern DRC, our teams are working to contain the spread of the Ebola disease outbreak and strengthen patient care, alongside the Ministry of Health. Learn about our response so far:
msf.org
Ebola disease in DRC: MSF scales up response to a rapidly evolving outbreak | MSF
In Democratic Republic of Congo, MSF teams are scaling up our response to the Ebola disease outbreak.
042
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 28/05/2026
👋 Meet Nombuso Ntshalintshali, our laboratory manager at Sitsandziwe clinic in Eswatini! Her lab uses a ‘test and treat’ approach, giving fast, accurate results for sexually transmitted infections so that patients can get targeted medications that reduce the risk of antibiotic resistance.
041
MSF Access @msfaccess.org · 27/05/2026
“A more equitable system can begin today if governments choose to act on the commitments they have already made in the Pandemic Agreement.” MSF statement at #WHA79, delivered by Yuanqiong Hu, Head of Analysis, MSF Access. Read the full statement: msfaccess.org/open-ended-i...
Yuanqiong Hu, Head of Analysis, MSF Access, delivering a statement at the 79th World Health Assembly in Geneva.
010
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 22/05/2026
🚨 Ebola in DRC Our teams are scaling up our response to the Ebola disease outbreak in DRC. How are we responding? What's different about this outbreak? Why are we concerned? Read the answers here ⬇️ 
msf.org
DRC Ebola outbreaks | MSF medical response
Learn more about the largest-ever Ebola outbreak in DRC and our response
043
MSF Access @msfaccess.org · 22/05/2026
🥁 We’re continuing our drumbeat call of analogue insulin pens for all at #WHA79. It’s time for countries & @who.int to end the double standard in diabetes care and include analogue insulin pens and glucose monitoring devices in all diabetes guidelines. msfaccess.org/follow-polit...
msfaccess.org
Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
MSF statement on noncommunicable diseases at the 79th World Health Assembly
000
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 21/05/2026
Why is this Ebola disease outbreak different? John Johnson, our medical lead for epidemic response, gave an interview to explain the Bundibugyo virus and its challenges:
msf.org
The Bundibugyo virus challenge: why is this Ebola disease outbreak different | MSF
In an interview, John Johnson, MSF's medical lead for epidemic response, explains the Bundibugyo virus and what makes this Ebola disease outbreak different.
033
MSF Access @msfaccess.org · 22/05/2026
“Immediately closing the devastating vaccination coverage gaps we’re seeing requires political will,” Dr Daniela Garone, MSF Read our call ahead of discussions on the progress towards reaching global immunisation goals #IA2030 at #WHA79. msfaccess.org/urgent-actio...
msfaccess.org
Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile ...
011
MSF Access @msfaccess.org · 21/05/2026
Read the statements 👉 msfaccess.org/msf-statemen...
000
MSF Access @msfaccess.org · 21/05/2026
This week, we're right here at the World Health Assembly #WHA79, calling for countries to make sure global health policies for the coming years ensure everyone, everywhere has access to affordable medical products.
132
MSF Access @msfaccess.org · 19/05/2026
MSF representatives will address critical health issues at the World Health Assembly #WHA79 this week, calling for urgent action on: 🦠Antimicrobial resistance 🩺Noncommunicable diseases 😷Pandemic preparedness & response 💉Vaccines Read the statements: msfaccess.org/msf-statemen...
msfaccess.org
MSF statements at WHO World Health Assembly 79th session
MSF statements on access to healthcare products at 79th World Health Assembly
011
MSF Access @msfaccess.org · 18/05/2026
📌Dedicating sustained and agile financing to ensure immunisation activities reach people in the world’s most fragile areas. msfaccess.org/urgent-actio...
msfaccess.org
Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile ...
000
MSF Access @msfaccess.org · 18/05/2026
📌Ensuring flexible and adapted delivery models to reach children in conflict settings and stop delays in people’s access to lifesaving vaccines.
An MSF vehicle transports staff as part of measles vaccination activities in the Masisi territory, North Kivu, DRC, 2025. © Joelle Kayembe Balilonda/MSF
100
MSF Access @msfaccess.org · 18/05/2026
📌Removing administrative and bureaucratic blockages and strengthening collaboration between health authorities, humanitarian partners, and communities to ensure timely and unhindered access to vaccine supplies and hard-to-reach areas.
Vaccination campaign as part of an MSF and Ministry of Health emergency measles and rubella response in El Geneina, Sudan. 2026. © Cindy Gonzalez /MSF
100
MSF Access @msfaccess.org · 18/05/2026
📢 This World Health Assembly #WHA79, we’re calling for countries, donors, and other global health stakeholders to urgently dismantle the barriers blocking access to lifesaving vaccination in conflict-affected settings by:
100
MSF Access @msfaccess.org · 15/05/2026
“As future outbreaks remain inevitable and lives continue to be at risk due to inequitable access, we strongly urge governments to act now,” Dr Guevara concluded. msfaccess.org/countries-mu...
msfaccess.org
Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
MSF calls on countries to prepare for early implementation of the Pandemic Agreement.
000
MSF Access @msfaccess.org · 15/05/2026
“Communities who share critical samples and data, and those most at risk during outbreaks and health emergencies cannot anymore be the last to benefit from medical innovation,” said Dr Maria Guevara, MSF International Medical Secretary.
100
MSF Access @msfaccess.org · 15/05/2026
Without the PABS annex, countries cannot ratify or implement the Pandemic Agreement, but major disagreements remain unresolved. Governments must advance negotiations toward a strong multilateral PABS framework to ensure access is based on enforceable benefit‑sharing.
100
MSF Access @msfaccess.org · 15/05/2026
Did you know that the Pandemic Agreement, signed one year ago, is still on hold because of an annex? Enter the PABS* annex! * Pathogen Access and Benefit Sharing
120
Reposted by MSF Access
Médecins Sans Frontières @msf.org · 10/05/2026
In South Kivu, Democratic Republic of Congo, a new challenge is disrupting healthcare. Funding withdrawals are making vital care inaccessible, particularly for pregnant women and newborns. Read our latest press release here ⬇️
msf.org
Eastern DRC: Minova is on the brink of a healthcare crisis | MSF
Obstetric care has become inaccessible to women in South Kivu, Democratic Republic of Congo, as donor organisations have recently withdrawn from the area.
022